Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950170-25-021435
Filing Date
2025-02-14
Accepted
2025-02-14 17:10:39
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 12443
2 EX-99.1 ck0001669811-ex99_1.pdf EX-99.1 71015
3 EX-99.2 ck0001669811-ex99_2.pdf EX-99.2 55764
  Complete submission text file 0000950170-25-021435.txt   189388
Mailing Address C/O BESSEMER VENTURE PARTNERS 1865 PALMER AVE LARCHMONT NY 01538
Business Address C/O BESSEMER VENTURE PARTNERS 1865 PALMER AVE LARCHMONT NY 01538 914-833-5300
BVP VII SPECIAL OPPORTUNITY FUND LP (Filed by) CIK: 0001459524 (see all company filings)

EIN.: 000000000 | State of Incorp.: XX
Type: SCHEDULE 13G

Mailing Address 3 VAN DE GRAAFF DRIVE SUITE 200 BURLINGTON MA 01803
Business Address 3 VAN DE GRAAFF DRIVE SUITE 200 BURLINGTON MA 01803 781-902-8800
FRACTYL HEALTH, INC. (Subject) CIK: 0001572616 (see all company filings)

EIN.: 273553477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-94430 | Film No.: 25630801
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)